Fani Kalala

483 citations

28 papers · 355 indexed · h-index 9

Immunology
- Immunodeficiency and Autoimmune Disorders 4
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 3
Genetics
- Chronic Lymphocytic Leukemia Research 3
Oncology
Cancer Research
Biological Psychiatry
Infectious Diseases
- SARS-CoV-2 and COVID-19 Research 4
Rheumatology
- Eosinophilic Disorders and Syndromes 4
Pulmonary and Respiratory Medicine
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3

Co-authors: Matthaios Speletas Anastasios E. Germenis Gedeon Loules Konstantinos I. Gourgoulianis Vaios Karanikas Theodora Kerenidi Μαρία Ζαμανάκου Chrysoula Marogianni
Cited by: Immunology Genetics Oncology
Partner nations: Greece Austria Germany

In The Last Decade

Fani Kalala

26 papers receiving 347 citations

Peers

Countries citing papers authored by Fani Kalala

Since Specialization

Citations

This map shows the geographic impact of Fani Kalala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fani Kalala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fani Kalala more than expected).

Fields of papers citing papers by Fani Kalala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fani Kalala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fani Kalala. The network helps show where Fani Kalala may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fani Kalala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fani Kalala Line = papers co-authored together Fani Kalala links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Clinical Anatomy of SARS-CoV-2 Variants of Concern in Central Greece During October 2020–July 2022 Ioanna Voulgaridi,Zacharoula Bogogiannidou,Katerina Dadouli,Achilleas P. Galanopoulos,Maria Kyritsi,Alexandros Vontas,Alexia Matziri,Konstantina Kola,Evangelia Vachtsioli,Lemonia Anagnostopoulos,Anastasia Tsispara,Katerina G. Oikonomou,Dimitris Babalis,Efthymia Petinaki,Maria Tseroni,Fani Kalala,Matthaios Speletas,Varvara Α. Mouchtouri,Christos Hadjichristodoulou	2024	1
2	Daily time series of 12 human thermal stress indices in Greece, aggregated at commune level (1998–2022) Georgios Charvalis,Michalis Koureas,Chloe Brimicombe,Chara Bogogiannidou,Fani Kalala,Varvara Α. Mouchtouri,Christos Hadjichristodoulou	2024	1
3	Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson’s Disease Patients and Healthy Controls Maria Georgoula,Panagiotis Ntavaroukas,Anastasia Androutsopoulou,Georgia Xiromerisiou,Fani Kalala,Matthaios Speletas,Eftihia Asprodini,Anna Vasilaki,Stamatia Papoutsopoulou	2024	1
4	Heterozygous SERPINA1 Defects and Their Impact on Clinical Manifestations of Patients with Predominantly Antibody Deficiencies Styliani Sarrou,Ioanna Voulgaridi,Athanasia Fousika,Katerina Dadouli,Olympia Margaritopoulou,Ιoannis Kakkas,Christos Hadjichristodoulou,Fani Kalala,Matthaios Speletas	2024	0
5	Levels of Natural Antibodies Before and After Immunoglobulin Replacement Treatment Affect the Clinical Phenotype in Common Variable Immunodeficiency Ioannis Sarrigeorgiou,Gerasimina Tsinti,Fani Kalala,Anastasios E. Germenis,Matthaios Speletas,Peggy Lymberi	2024	2
6	Measles Immunity Status of Greek Population after the Outbreak in 2017–2018: Results from a Seroprevalence National Survey Asimina Nasika,Zacharoula Bogogiannidou,Varvara Α. Mouchtouri,Katerina Dadouli,Maria Kyritsi,Alexandros Vontas,Ioanna Voulgaridi,Zafeiris Tsinaris,Konstantina Kola,Alexia Matziri,Athanasios G. Lianos,Fani Kalala,Efthimia Petinaki,Matthaios Speletas,Christos Hadjichristodoulou	2023	2
7	Dynamics of Anti-SARS-CoV-2 IgA and IgG Responses and Their Protective Effect against Fatal Disease after Booster COVID-19 Vaccination Matthaios Speletas,Ioanna Voulgaridi,Zacharoula Bogogiannidou,Styliani Sarrou,Maria Kyritsi,Aikaterini Theodoridou,Katerina Dadouli,Alexia Matziri,Alexandros Vontas,Dimitra Pappa,Adamos-Konstantinos Konstantinou,Christina Tsigalou,Fani Kalala,Varvara Α. Mouchtouri,Christos Hadjichristodoulou	2023	4
8	Peripheral Inflammatory Markers TNF-α and CCL2 Revisited: Association with Parkinson’s Disease Severity Georgia Xiromerisiou,Chrysoula Marogianni,Ioannis C. Lampropoulos,Efthimios Dardiotis,Matthaios Speletas,Panagiotis Ntavaroukas,Anastasia Androutsopoulou,Fani Kalala,Nikolaos Grigoriadis,Stamatia Papoutsopoulou	2022	33
9	The rs1883832 Polymorphism (CD40-1C>T) Affects the Intensity of IgA Responses after BNT162b2 Vaccination Matthaios Speletas,Evangelos Bakaros,Athanasia-Marina Peristeri,Ioanna Voulgaridi,Styliani Sarrou,Vassiliki Paliatsa,Asimina Nasika,Maria Tseroni,Lemonia Anagnostopoulos,Kalliopi Theodoridou,Fani Kalala,Aikaterini Theodoridou,Varvara Α. Mouchtouri,Sotirios Tsiodras,Hermann Eibel,Christos Hadjichristodoulou	2022	4
10	Tumor Protein 53 Gene Mutations Without 17p13 Deletion Have No Significant Clinical Implications in Chronic Lymphocytic Leukemia. Detection of a New Mutation Panagiotis Diamantopoulos,S. Samara,Panagoula Κollia,Nefeli Giannakopoulou,Maria Sofotasiou,Fani Kalala,Elina Kodandreopoulou,Panagiotis Zervakis,Theodoros P. Vassilakopoulos,Marina P. Siakantaris,Marina Mantzourani,Maria K. Angelopoulou,MARIE-CHRISTINE KYRTSHONIS,Penelope Korkolopoulou,Efstathios Patsouris,Nora‐Athina Viniou	2017	4
11	Survivin Messenger RNA Levels in Epstein-Barr Virus–Positive Patients With Leukemic Low-Grade B-Cell Lymphomas Expressing the Latent Membrane Protein 1: Evidence of Apoptotic Function? Panagiotis Diamantopoulos,Katerina Polonyfi,Maria Sofotasiou,Marina Mantzourani,Athanassios Galanopoulos,Nikolaos Spanakis,Vasiliki Papadopoulou,Fani Kalala,Theodoros Iliakis,Danai-Stella Zareifi,Elina Kodandreopoulou,Theodoros P. Vassilakopoulos,Maria K. Angelopoulou,Marina P. Siakantaris,Evangelos Terpos,Eleni Variami,Panagoula Κollia,George Vaiopoulos,Gerassimos A. Pangalis,Nora‐Athina Viniou	2013	2
12	Transient Ischemic Attacks as the First Presentation of JAK2-V617F Positive Chronic Myeloproliferative Neoplasm Fani Kalala,Antigoni Mamara,Μαρία Ιωάννου,Matthaios Speletas	2012	5
13	FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia Gedeon Loules,Fani Kalala,Nikolaos Giannakoulas,Emmanouil Papadakis,Panagiota Matsouka,Matthaios Speletas	2009	14
14	TLR2 and TLR4 polymorphisms in familial Mediterranean fever Matthaios Speletas,Fani Kalala,Ioannis Mitroulis,Vasileios Papadopoulos,Vassiliki Merentiti,Anastasios E. Germenis,Konstantinos Ritis	2009	11
15	Pneumonia caused byCandida kruseiandCandida glabratain a patient with chronic myeloid leukemia receiving imatinib mesylate treatment Matthaios Speletas,Timoleon‐Achilleas Vyzantiadis,Fani Kalala,Dimitrios Plastiras,Kyriaki Kokoviadou,Antonios P. Antoniadis,Ioannis Korantzis	2008	19
16	Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individuals Vaios Karanikas,Faye Soukou,Fani Kalala,Theodora Kerenidi,Evangelia S. Grammoustianou,Konstantinos I. Gourgoulianis,Anastasios E. Germenis	2008	14
17	Foxp3 expression in human cancer cells Vaios Karanikas,Matthaios Speletas,Μαρία Ζαμανάκου,Fani Kalala,Gedeon Loules,Theodora Kerenidi,Angeliki K. Barda,Konstantinos I. Gourgoulianis,Anastasios E. Germenis	2008	173
18	Radiofrequency-assisted partial splenectomy: Histopathological and immunological assessment of the splenic remnant in a porcine model Dimitris Zacharoulis,A Poultsidis,Emmanuel Katsogridakis,Fani Kalala,Marianna Nakou,Constantine Chatzitheofilou	2007	11
19	TLR4 single nucleotide polymorphisms and thrombosis risk in patients with myeloproliferative disorders Matthaios Speletas,Kyriaki Liadaki,Fani Kalala,Chrisoula Daiou,Eirini Katodritou,Ευδοκία Μανδαλά,Ippokratis Korantzis,Konstantinos Ritis,Ηλίας Ζιντζαράς,Anastasios E. Germenis	2007	3
20	Pulmonary arterial hypertension in a patient with common variable immunodeficiency and unilateral bronchiectasis: Successful treatment with iloprost Zoe Daniil,Eleni Karetsi,Epaminondas Zakynthinos,Efrosini Bakratsi,Fani Kalala,K. Gourgoulianis	2007	5

About Fani Kalala

Fani Kalala is a scholar working on Immunology, Genetics and Infectious Diseases, having authored 28 papers that have together received 355 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Eosinophilic Disorders and Syndromes (4 papers), Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (182 citations), Genetics (36 citations) and Oncology (91 citations). Fani Kalala has collaborated with scholars based in Greece, Austria and Germany. Frequent co-authors include Matthaios Speletas, Anastasios E. Germenis, Gedeon Loules, Konstantinos I. Gourgoulianis, Vaios Karanikas, Theodora Kerenidi, Μαρία Ζαμανάκου, Chrysoula Marogianni, Georgia Xiromerisiou and Stamatia Papoutsopoulou.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact